Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Sky Pharmaceuticals (DLSK) is a prominent Chinese pharmaceutical and medical device company founded in 1990 and headquartered in Dalian. The company operates as a comprehensive supply chain solution provider, specializing in the export of over 800 types of finished drugs, active pharmaceutical ingredients (APIs), and advanced medical equipment to global markets. DLSK is a world leader in the production of lactulose and medical-grade mannitol, utilizing large-scale GMP-certified manufacturing facilities with an annual capacity exceeding 2,000 tons. Its portfolio spans diverse therapeutic areas including oncology, endocrinology, and neurology, featuring both innovative original drugs and high-quality generics. Additionally, the company provides cutting-edge medical technologies, such as surgical robots and diagnostic imaging systems, to healthcare institutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DLSK Pharma.